Search Results

Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel.

• Authors : Ben-Aharon, Omer; Sergienko, Ruslan; Iskrov, Georgi

Subjects: CONTINGENT valuation; WILLINGNESS to pay; MESSENGER RNAISRAEL

• Source: Israel Journal of Health Policy Research; 2/19/2024, Vol. 13, p1-17, 17p

Record details

Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination.

• Authors : Echaide, Miriam; Labiano, Ibone; Delgado, Marina

Subjects: COVID-19; IMMUNIZATION; CANCER patients

• Source: Cancers; Sep2022, Vol. 14 Issue 18, pN.PAG-N.PAG, 17p

Record details

Cancer mRNA Vaccines as a Promising Approach for Treating Luminal A Breast Cancer.

• Authors : Giuliani, Alexandra

Subjects: BREAST cancer treatment; CANCER vaccines; MESSENGER RNA

• Source: International Journal of High School Research; Aug2022, Vol. 4 Issue 4, p48-53, 6p

Record details

From Vaccines to Oncology and Beyond: Tracking mRNA's Progress: The success of mRNA-based vaccines paves the way for mRNA in oncology and beyond.

• Authors : MIRASOL, FELIZA

Subjects: THERAPEUTIC use of monoclonal antibodies; THERAPEUTICS; COVID-19 vaccines

• Source: BioPharm International; Jan2024, Vol. 37 Issue 1, p14-17, 3p

Record details

AbbVie Partners with Immunome and Anima in Oncology-Focused Deals.

• Authors : Haggerty, Lucy¹

Subjects: MESSENGER RNA; LIGHTNING; ONCOLOGY

• Source: PharmaDeals Review. Jan2023, Vol. 2023 Issue 1, p3-3. 1p.

Record details

Moderna Signs US$1.2 B Collaboration with Oncology Specialist CytomX.

• Authors : Haggerty, Lucy¹

Subjects: *LICENSE agreements; MESSENGER RNA; ONCOLOGY

• Source: PharmaDeals Review. Jan2023, Vol. 2023 Issue 1, p1-1. 1p.

Record details

AbbVie, following in footsteps of Lilly and Takeda, pays Anima $42M to go after undruggable targets.

• Authors : Taylor, Nick Paul (AUTHOR)

Subjects: FOOTSTEPS; MESSENGER RNA

• Source: FierceBiotech. 1/10/2023, pN.PAG-N.PAG. 1p.

Record details

MicroRNA expression profiles classify human cancers.

• Authors : Lu, Jun; Getz, Gad; Miska, Eric A.

Subjects: MESSENGER RNA; CANCER diagnosis; ONCOLOGY

• Source: Nature. 6/9/2005, Vol. 435 Issue 7043, p834-838. 5p.

Record details

PITAR, a DNA damage-inducible Cancer/Testis long noncoding RNA, inactivates p53 by binding and stabilizing TRIM28 mRNA (Updated April 1, 2024).

Subjects: LINCRNA; DNA repair; SYNCRIP protein

• Source: Clinical Oncology Week; 4/16/2024, p785-785, 1p

Record details

Patent Issued for Compositions and methods for organ-protective expression and modulation of coding ribonucleic acids (USPTO 11931409).

Subjects: GENE expression; RNA; MODULATION coding

• Source: Cancer Vaccine Week; 4/8/2024, p155-155, 1p

Record details